Gadoxetate disodium-enhanced MRI: assessment of arterial phase artifacts and hepatobiliary uptake in a large series

Abstract Purpose To report the quality of gadoxetate disodium MRI in a large series by assessing the prevalence of: 1) arterial phase (AP) artifacts and its predictive factors, 2) decreased hepatic contrast uptake during the hepatobiliary phase (HBP). Methods This retrospective single center study included 851 patients (M/F:537/314, mean age: 63y) with gadoxetate disodium MRI. The MRI protocol included unenhanced, dual arterial [early and late arterial phases (AP)], portal venous, transitional and hepatobiliary phases. Three radiologists graded dynamic images using a 5-scale score (1: no motion, 5: severe, nondiagnostic) for assessment of transient severe motion (TSM, defined as a score ≥4 during at least one AP with a score ≤3 during other phases). HBP uptake was assessed using a 3-scale score (based on portal vein/hepatic signal). The association between demographic, clinical and acquisition parameters with TSM was tested in uni- and multivariate logistic regression. Results TSM was observed in 103/851 patients (12.1%): 83 (9.8%) in one AP and 20 (2.3%) in both APs. A score of 5 (nondiagnostic) was assigned in 7 patients in one AP (0.8%) and none in both. Presence of TSM was significantly associated with age (p = 0.002) and liver disease (p = 0.033) in univariate but not in multivariate analysis (p > 0.05). No association was found between acquisition parameters and TSM occurrence. Limited or severely limited HBP contrast uptake was observed in 87 patients (10.2%), and TSM was never associated with severely limited HBP contrast uptake. Conclusion TSM was present in approximately 12% of gadoxetate disodium MRIs, rarely on both APs (2.3%), and was poorly predicted. TSM was never associated with severely limited HBP contrast uptake.